Press Release Sep 07 2026 09: 40: 56
Filed with NSE · · 4 pages · English
Summary by 6ix AI
The company reported total income significantly higher than the same quarter last year, driven by increased consumption of Truenat test kits. EBITDA and profit after tax also showed substantial improvement compared to the previous year, reflecting operational leverage and growth in revenue. Management emphasized the importance of assessing performance on a full-year basis due to the non-linear revenue profile of the business.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Molbio Diagnostics Limited on 6ix
In the deck
Follow Molbio Diagnostics into a list and get an email when it puts out news.
Follow Molbio Diagnostics